Literature DB >> 21869871

Fecal biomarkers for the diagnosis and management of inflammatory bowel disease.

Gert Van Assche1.   

Abstract

Entities:  

Year:  2011        PMID： 21869871      PMCID： PMC3151412     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN： 1554-7914


× No keyword cloud information.
  7 in total

1.  Fecal calprotectin as a measure of disease activity in childhood inflammatory bowel disease.

Authors:  S K Bunn; W M Bisset; M J Main; B E Golden
Journal:  J Pediatr Gastroenterol Nutr       Date:  2001-02       Impact factor: 2.839

2.  Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease.

Authors:  F Costa; M G Mumolo; L Ceccarelli; M Bellini; M R Romano; C Sterpi; A Ricchiuti; S Marchi; M Bottai
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

3.  Faecal calprotectin and lactoferrin are reliable surrogate markers of endoscopic response during Crohn's disease treatment.

Authors:  Taina Sipponen; Clas-Göran A F Björkesten; Martti Färkkilä; Hannu Nuutinen; Erkki Savilahti; Kaija-Leena Kolho
Journal:  Scand J Gastroenterol       Date:  2010-03       Impact factor: 2.423

4.  Fecal calprotectin levels in healthy children studied with an improved assay.

Authors:  Ulrika Lorentzon Fagerberg; Lars Lööf; Rumjana Djilali Merzoug; Lars-Olof Hansson; Yigael Finkel
Journal:  J Pediatr Gastroenterol Nutr       Date:  2003-10       Impact factor: 2.839

5.  Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.

Authors:  Alain M Schoepfer; Christoph Beglinger; Alex Straumann; Michael Trummler; Stephan R Vavricka; Lukas E Bruegger; Frank Seibold
Journal:  Am J Gastroenterol       Date:  2009-09-15       Impact factor: 10.864

Review 6.  Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease.

Authors:  J P Gisbert; A G McNicholl
Journal:  Dig Liver Dis       Date:  2008-07-03       Impact factor: 4.088

7.  Fecal lactoferrin is a sensitive and specific marker in identifying intestinal inflammation.

Authors:  Sunanda V Kane; William J Sandborn; Paul A Rufo; Anna Zholudev; James Boone; David Lyerly; Michael Camilleri; Stephen B Hanauer
Journal:  Am J Gastroenterol       Date:  2003-06       Impact factor: 10.864
  7 in total
  4 in total

1.  Association of enteric parasitic infections with intestinal inflammation and permeability in asymptomatic infants of São Tomé Island.

Authors:  Marisol Garzón; Luis Pereira-da-Silva; Jorge Seixas; Ana Luísa Papoila; Marta Alves; Filipa Ferreira; Ana Reis
Journal:  Pathog Glob Health       Date:  2017-03-10       Impact factor: 2.894

2.  Comparisons between myeloperoxidase, lactoferrin, calprotectin and lipocalin-2, as fecal biomarkers of intestinal inflammation in malnourished children.

Authors:  Mara de Moura Gondim Prata; A Havt; D T Bolick; R Pinkerton; Aam Lima; R L Guerrant
Journal:  J Transl Sci       Date:  2016-03-25

3.  Diagnostic accuracy of fecal calprotectin in assessing the severity of inflammatory bowel disease: From laboratory to clinic.

Authors:  Soheila Moein; Durdi Qujeq; Mostafa Vaghari Tabari; Mehrdad Kashifard; Karimollah Hajian-Tilaki
Journal:  Caspian J Intern Med       Date:  2017

4.  Fecal Galectin-3: A New Promising Biomarker for Severity and Progression of Colorectal Carcinoma.

Authors:  Milan Jovanovic; Nevena Gajovic; Natasa Zdravkovic; Marina Jovanovic; Milena Jurisevic; Danilo Vojvodic; Veljko Maric; Aleksandar Arsenijevic; Ivan Jovanovic
Journal:  Mediators Inflamm       Date:  2018-04-04       Impact factor: 4.711
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.